Somac 40 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

somac 40 mg

takeda as - pantoprazolnatriumsesquihydrat - enterotablett - 40 mg

Somac 20 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

somac 20 mg

orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg

Somac 20 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

somac 20 mg

orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg

Somac 40 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

somac 40 mg

orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 40 mg

Pantoprazol Oresund Pharma 40 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

pantoprazol oresund pharma 40 mg

oresund pharma aps - pantoprazolnatriumsesquihydrat - pulver til injeksjonsvæske, oppløsning - 40 mg

Somac 40 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

somac 40 mg

orifarm as - pantoprazolnatriumsesquihydrat - pulver til injeksjonsvæske, oppløsning - 40 mg

Pemetrexed Baxter Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiske midler - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Dabigatran Etexilate Accord Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

dabigatran etexilate accord

accord healthcare s.l.u. - dabigatran etexilate mesilate - venous thromboembolism; arthroplasty, replacement - antithrombotic agents - prevention of venous thromboembolic events.